Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Accenture
Merck
Julphar
QuintilesIMS
Colorcon

Generated: July 20, 2019

DrugPatentWatch Database Preview

Patent: 8,691,506

Try a free trialSee Plans and Pricing

« Back to Dashboard

Summary for Patent: 8,691,506
Title:Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds
Abstract: The present invention relates to a method for providing a gene expression profile being predictive for the specific response of an individual tumor to a pharmaceutically effective compound, the use thereof, a microarray wherein the nucleotide sequences attached to the substrate consist of nucleotide sequences corresponding to the predictive genes of said gene expression profile, and a diagnostic kit containing said microarray.
Inventor(s): Bausch; Niko (Freiburg, DE), Fiebig; Heinz-Herbert (Freiburg, DE), Korrat; Andre (Freiburg, DE), Maurer; Martina (Freiburg, DE), Metz; Thomas (Glottertal, DE), Schuler; Julia (Freiburg, DE)
Assignee: Oncotest GmbH (Freiburg, DE)
Application Number:11/911,222
Patent Claims:see list of patent claims

Details for Patent 8,691,506

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 002 2004-02-26 ➤ Try a Free Trial Oncotest GmbH (Freiburg, DE) ➤ Try a Free Trial RX search
Genentech AVASTIN bevacizumab VIAL; INTRAVENOUS 125085 001 2004-02-26 ➤ Try a Free Trial Oncotest GmbH (Freiburg, DE) ➤ Try a Free Trial RX search
Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Patent Expiration Status Orphan Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Covington
Deloitte
US Army
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.